Cost-Effective Lapatinib Ditosylate Monohydrate Powder: Advanced Treatment for HER2-Positive Breast Cancer
Empower your treatment strategies with high-purity Lapatinib Ditosylate Monohydrate, a key solution for advanced breast cancer.
Get a Quote & SampleProduct Core Value
Lapatinib Ditosylate Monohydrate
This advanced pharmaceutical ingredient is specifically designed for the treatment of women's breast cancer, offering a cost-effective solution for patients with HER2-positive advanced breast cancer that has progressed after prior therapies.
- Experience a cost-effective solution for HER2-positive breast cancer treatment, ensuring accessibility for more patients.
- Benefit from a potent receptor TK inhibitor targeting ErbB-1 and ErbB-2 subtypes, crucial for managing specific cancer cell lines.
- Explore advanced breast cancer therapy options with an agent that dissociates slowly from receptor TKs for sustained effect.
- Utilize high purity Lapatinib Ditosylate Monohydrate for effective treatment, supporting optimal patient outcomes in oncology.
Advantages of the Product
Targeted Action
Leverage the targeted action of this agent, a key strategy in advanced breast cancer therapy, offering precision against ErbB-1 and ErbB-2 overexpression.
Improved Efficacy
Enhance treatment efficacy through its mechanism as a receptor TK inhibitor, crucial for patients seeking effective women's breast cancer treatment.
Cost-Effectiveness
Access a cost-effective solution for advanced breast cancer management, making essential therapies more attainable.
Key Applications
HER2-Positive Breast Cancer Treatment
A primary application focuses on treating HER2-positive advanced breast cancer, a critical area in women's breast cancer treatment.
ER+/EGFR+/HER2+ Breast Cancer
This compound is suitable for treatment-naïve patients with ER+/EGFR+/HER2+ breast cancer, broadening its utility.
Post-Chemotherapy Treatment
Effective for patients whose HER2-positive advanced breast cancer has progressed after previous treatments like anthracycline or taxane-derived drugs.
Oncology Research and Development
Serves as a vital component in oncology research and the development of new targeted therapies for various cancers.